ReviewBiomedicines2022

Mesenchyme Stem Cell-Derived Conditioned Medium as a Potential Therapeutic Tool in Idiopathic Pulmonary Fibrosis.

George Kolios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.